Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Boston Scientific announces positive results from its Champion-Af study

Boston Scientific announces positive results from its Champion-Af study

老虎证券老虎证券2026/03/28 15:27
Show original
The study evaluated the performance of the Watchman Flx™ left atrial appendage occluder as a first-line therapy for reducing stroke risk. Research data show that the Watchman Flx™ device met all predefined primary safety endpoints and primary efficacy endpoints. At the same time, all secondary safety and efficacy endpoints were also successfully achieved. These results indicate that, as a first-line therapy, the device demonstrates excellent safety and efficacy, offering an important new option for stroke prevention.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!